nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—CYP2B6—Thiotepa—urinary bladder cancer	0.187	0.308	CbGbCtD
Clobazam—ABCB1—Mitomycin—urinary bladder cancer	0.126	0.208	CbGbCtD
Clobazam—CYP3A4—Thiotepa—urinary bladder cancer	0.0573	0.0946	CbGbCtD
Clobazam—CYP2B6—Cisplatin—urinary bladder cancer	0.0515	0.085	CbGbCtD
Clobazam—ABCB1—Gemcitabine—urinary bladder cancer	0.0363	0.06	CbGbCtD
Clobazam—CYP2B6—Doxorubicin—urinary bladder cancer	0.0345	0.057	CbGbCtD
Clobazam—ABCB1—Cisplatin—urinary bladder cancer	0.0264	0.0436	CbGbCtD
Clobazam—ABCB1—Etoposide—urinary bladder cancer	0.0259	0.0428	CbGbCtD
Clobazam—ABCB1—Doxorubicin—urinary bladder cancer	0.0177	0.0292	CbGbCtD
Clobazam—ABCB1—Methotrexate—urinary bladder cancer	0.0171	0.0283	CbGbCtD
Clobazam—CYP3A4—Etoposide—urinary bladder cancer	0.0155	0.0257	CbGbCtD
Clobazam—CYP3A4—Doxorubicin—urinary bladder cancer	0.0106	0.0175	CbGbCtD
Clobazam—SLC6A1—prostate gland—urinary bladder cancer	0.00639	0.172	CbGeAlD
Clobazam—SLC6A1—seminal vesicle—urinary bladder cancer	0.0054	0.146	CbGeAlD
Clobazam—CYP2C19—urine—urinary bladder cancer	0.00471	0.127	CbGeAlD
Clobazam—SLC6A1—urethra—urinary bladder cancer	0.00428	0.115	CbGeAlD
Clobazam—SLC6A1—female reproductive system—urinary bladder cancer	0.00349	0.094	CbGeAlD
Clobazam—CYP3A4—urine—urinary bladder cancer	0.00279	0.0751	CbGeAlD
Clobazam—Midazolam—CYP4B1—urinary bladder cancer	0.00275	0.402	CrCbGaD
Clobazam—CYP2C18—vagina—urinary bladder cancer	0.00196	0.0529	CbGeAlD
Clobazam—Flunitrazepam—UGT2B7—urinary bladder cancer	0.00147	0.215	CrCbGaD
Clobazam—Oxazepam—UGT2B7—urinary bladder cancer	0.00114	0.167	CrCbGaD
Clobazam—CYP2B6—renal system—urinary bladder cancer	0.000903	0.0243	CbGeAlD
Clobazam—CYP2C19—vagina—urinary bladder cancer	0.000835	0.0225	CbGeAlD
Clobazam—CYP2B6—female reproductive system—urinary bladder cancer	0.000723	0.0195	CbGeAlD
Clobazam—ABCB1—prostate gland—urinary bladder cancer	0.000708	0.0191	CbGeAlD
Clobazam—CYP3A4—renal system—urinary bladder cancer	0.000682	0.0184	CbGeAlD
Clobazam—Clomipramine—GSTP1—urinary bladder cancer	0.000662	0.0967	CrCbGaD
Clobazam—CYP2B6—vagina—urinary bladder cancer	0.000654	0.0176	CbGeAlD
Clobazam—ABCB1—seminal vesicle—urinary bladder cancer	0.000599	0.0161	CbGeAlD
Clobazam—CYP3A4—female reproductive system—urinary bladder cancer	0.000546	0.0147	CbGeAlD
Clobazam—ABCB1—epithelium—urinary bladder cancer	0.00052	0.014	CbGeAlD
Clobazam—ABCB1—renal system—urinary bladder cancer	0.000482	0.013	CbGeAlD
Clobazam—ABCB1—urethra—urinary bladder cancer	0.000474	0.0128	CbGeAlD
Clobazam—Antipyrine—PTGS2—urinary bladder cancer	0.000474	0.0692	CrCbGaD
Clobazam—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.000388	0.00187	CcSEcCtD
Clobazam—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000388	0.00187	CcSEcCtD
Clobazam—Asthma—Methotrexate—urinary bladder cancer	0.000387	0.00187	CcSEcCtD
Clobazam—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.000387	0.00187	CcSEcCtD
Clobazam—ABCB1—female reproductive system—urinary bladder cancer	0.000386	0.0104	CbGeAlD
Clobazam—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000386	0.00186	CcSEcCtD
Clobazam—Eosinophilia—Methotrexate—urinary bladder cancer	0.000383	0.00185	CcSEcCtD
Clobazam—Insomnia—Fluorouracil—urinary bladder cancer	0.000383	0.00185	CcSEcCtD
Clobazam—Somnolence—Gemcitabine—urinary bladder cancer	0.000383	0.00185	CcSEcCtD
Clobazam—Anorexia—Cisplatin—urinary bladder cancer	0.000382	0.00185	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000381	0.00184	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000377	0.00182	CcSEcCtD
Clobazam—Somnolence—Fluorouracil—urinary bladder cancer	0.000376	0.00182	CcSEcCtD
Clobazam—Hypotension—Cisplatin—urinary bladder cancer	0.000375	0.00181	CcSEcCtD
Clobazam—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000374	0.00181	CcSEcCtD
Clobazam—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000372	0.00179	CcSEcCtD
Clobazam—Fatigue—Gemcitabine—urinary bladder cancer	0.000371	0.00179	CcSEcCtD
Clobazam—Confusional state—Etoposide—urinary bladder cancer	0.000371	0.00179	CcSEcCtD
Clobazam—Muscular weakness—Epirubicin—urinary bladder cancer	0.00037	0.00178	CcSEcCtD
Clobazam—Constipation—Gemcitabine—urinary bladder cancer	0.000368	0.00178	CcSEcCtD
Clobazam—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000368	0.00178	CcSEcCtD
Clobazam—Asthenia—Thiotepa—urinary bladder cancer	0.000367	0.00177	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000365	0.00176	CcSEcCtD
Clobazam—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000365	0.00176	CcSEcCtD
Clobazam—Infection—Etoposide—urinary bladder cancer	0.000365	0.00176	CcSEcCtD
Clobazam—Abdominal distension—Epirubicin—urinary bladder cancer	0.000365	0.00176	CcSEcCtD
Clobazam—Ataxia—Doxorubicin—urinary bladder cancer	0.000365	0.00176	CcSEcCtD
Clobazam—Asthma—Epirubicin—urinary bladder cancer	0.000362	0.00175	CcSEcCtD
Clobazam—Dysphagia—Epirubicin—urinary bladder cancer	0.000362	0.00175	CcSEcCtD
Clobazam—Pruritus—Thiotepa—urinary bladder cancer	0.000362	0.00175	CcSEcCtD
Clobazam—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00036	0.00174	CcSEcCtD
Clobazam—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00036	0.00174	CcSEcCtD
Clobazam—Eosinophilia—Epirubicin—urinary bladder cancer	0.000359	0.00173	CcSEcCtD
Clobazam—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000358	0.00173	CcSEcCtD
Clobazam—Skin disorder—Etoposide—urinary bladder cancer	0.000357	0.00172	CcSEcCtD
Clobazam—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000355	0.00171	CcSEcCtD
Clobazam—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000355	0.00171	CcSEcCtD
Clobazam—Anorexia—Etoposide—urinary bladder cancer	0.00035	0.00169	CcSEcCtD
Clobazam—Diarrhoea—Thiotepa—urinary bladder cancer	0.00035	0.00169	CcSEcCtD
Clobazam—ABCB1—vagina—urinary bladder cancer	0.000349	0.00942	CbGeAlD
Clobazam—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000349	0.00169	CcSEcCtD
Clobazam—Decreased appetite—Cisplatin—urinary bladder cancer	0.000349	0.00168	CcSEcCtD
Clobazam—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000349	0.00168	CcSEcCtD
Clobazam—Bronchitis—Epirubicin—urinary bladder cancer	0.000348	0.00168	CcSEcCtD
Clobazam—Phenylbutazone—PTGS2—urinary bladder cancer	0.000347	0.0508	CrCbGaD
Clobazam—Pneumonia—Methotrexate—urinary bladder cancer	0.000347	0.00168	CcSEcCtD
Clobazam—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000346	0.00167	CcSEcCtD
Clobazam—Infestation NOS—Methotrexate—urinary bladder cancer	0.000345	0.00167	CcSEcCtD
Clobazam—Infestation—Methotrexate—urinary bladder cancer	0.000345	0.00167	CcSEcCtD
Clobazam—Drowsiness—Methotrexate—urinary bladder cancer	0.000345	0.00167	CcSEcCtD
Clobazam—Depression—Methotrexate—urinary bladder cancer	0.000344	0.00166	CcSEcCtD
Clobazam—Hypotension—Etoposide—urinary bladder cancer	0.000343	0.00166	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000342	0.00165	CcSEcCtD
Clobazam—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000342	0.00165	CcSEcCtD
Clobazam—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00034	0.00164	CcSEcCtD
Clobazam—Dizziness—Thiotepa—urinary bladder cancer	0.000338	0.00163	CcSEcCtD
Clobazam—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000337	0.00163	CcSEcCtD
Clobazam—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000337	0.00163	CcSEcCtD
Clobazam—Urticaria—Fluorouracil—urinary bladder cancer	0.000336	0.00162	CcSEcCtD
Clobazam—Dysphagia—Doxorubicin—urinary bladder cancer	0.000335	0.00162	CcSEcCtD
Clobazam—Asthma—Doxorubicin—urinary bladder cancer	0.000335	0.00162	CcSEcCtD
Clobazam—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000334	0.00161	CcSEcCtD
Clobazam—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000332	0.0016	CcSEcCtD
Clobazam—Sweating—Methotrexate—urinary bladder cancer	0.000331	0.0016	CcSEcCtD
Clobazam—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000331	0.0016	CcSEcCtD
Clobazam—Weight increased—Epirubicin—urinary bladder cancer	0.00033	0.00159	CcSEcCtD
Clobazam—Somnolence—Etoposide—urinary bladder cancer	0.000327	0.00158	CcSEcCtD
Clobazam—Vomiting—Thiotepa—urinary bladder cancer	0.000325	0.00157	CcSEcCtD
Clobazam—Pneumonia—Epirubicin—urinary bladder cancer	0.000325	0.00157	CcSEcCtD
Clobazam—Infestation NOS—Epirubicin—urinary bladder cancer	0.000323	0.00156	CcSEcCtD
Clobazam—Infestation—Epirubicin—urinary bladder cancer	0.000323	0.00156	CcSEcCtD
Clobazam—Drowsiness—Epirubicin—urinary bladder cancer	0.000323	0.00156	CcSEcCtD
Clobazam—Rash—Thiotepa—urinary bladder cancer	0.000323	0.00156	CcSEcCtD
Clobazam—Bronchitis—Doxorubicin—urinary bladder cancer	0.000322	0.00156	CcSEcCtD
Clobazam—Dermatitis—Thiotepa—urinary bladder cancer	0.000322	0.00156	CcSEcCtD
Clobazam—Headache—Thiotepa—urinary bladder cancer	0.00032	0.00155	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00032	0.00155	CcSEcCtD
Clobazam—Decreased appetite—Etoposide—urinary bladder cancer	0.000319	0.00154	CcSEcCtD
Clobazam—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000317	0.00153	CcSEcCtD
Clobazam—Body temperature increased—Cisplatin—urinary bladder cancer	0.000317	0.00153	CcSEcCtD
Clobazam—Fatigue—Etoposide—urinary bladder cancer	0.000317	0.00153	CcSEcCtD
Clobazam—Constipation—Etoposide—urinary bladder cancer	0.000314	0.00152	CcSEcCtD
Clobazam—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000314	0.00152	CcSEcCtD
Clobazam—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000312	0.0015	CcSEcCtD
Clobazam—Sweating—Epirubicin—urinary bladder cancer	0.00031	0.00149	CcSEcCtD
Clobazam—Asthenia—Gemcitabine—urinary bladder cancer	0.000309	0.00149	CcSEcCtD
Clobazam—Weight increased—Doxorubicin—urinary bladder cancer	0.000305	0.00147	CcSEcCtD
Clobazam—Pruritus—Gemcitabine—urinary bladder cancer	0.000304	0.00147	CcSEcCtD
Clobazam—Nausea—Thiotepa—urinary bladder cancer	0.000304	0.00147	CcSEcCtD
Clobazam—Feeling abnormal—Etoposide—urinary bladder cancer	0.000303	0.00146	CcSEcCtD
Clobazam—Pneumonia—Doxorubicin—urinary bladder cancer	0.000301	0.00145	CcSEcCtD
Clobazam—Pruritus—Fluorouracil—urinary bladder cancer	0.000299	0.00145	CcSEcCtD
Clobazam—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000299	0.00144	CcSEcCtD
Clobazam—Infestation—Doxorubicin—urinary bladder cancer	0.000299	0.00144	CcSEcCtD
Clobazam—Drowsiness—Doxorubicin—urinary bladder cancer	0.000299	0.00144	CcSEcCtD
Clobazam—Visual impairment—Methotrexate—urinary bladder cancer	0.000299	0.00144	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000296	0.00143	CcSEcCtD
Clobazam—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000294	0.00142	CcSEcCtD
Clobazam—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000293	0.00141	CcSEcCtD
Clobazam—Urticaria—Etoposide—urinary bladder cancer	0.000292	0.00141	CcSEcCtD
Clobazam—Body temperature increased—Etoposide—urinary bladder cancer	0.00029	0.0014	CcSEcCtD
Clobazam—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00029	0.0014	CcSEcCtD
Clobazam—Eye disorder—Methotrexate—urinary bladder cancer	0.00029	0.0014	CcSEcCtD
Clobazam—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00029	0.0014	CcSEcCtD
Clobazam—Asthenia—Cisplatin—urinary bladder cancer	0.000288	0.00139	CcSEcCtD
Clobazam—Sweating—Doxorubicin—urinary bladder cancer	0.000286	0.00138	CcSEcCtD
Clobazam—Dizziness—Fluorouracil—urinary bladder cancer	0.00028	0.00135	CcSEcCtD
Clobazam—Visual impairment—Epirubicin—urinary bladder cancer	0.000279	0.00135	CcSEcCtD
Clobazam—Diarrhoea—Cisplatin—urinary bladder cancer	0.000274	0.00132	CcSEcCtD
Clobazam—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000274	0.00132	CcSEcCtD
Clobazam—Vomiting—Gemcitabine—urinary bladder cancer	0.000274	0.00132	CcSEcCtD
Clobazam—Mental disorder—Methotrexate—urinary bladder cancer	0.000271	0.00131	CcSEcCtD
Clobazam—Rash—Gemcitabine—urinary bladder cancer	0.000271	0.00131	CcSEcCtD
Clobazam—Dermatitis—Gemcitabine—urinary bladder cancer	0.000271	0.00131	CcSEcCtD
Clobazam—Eye disorder—Epirubicin—urinary bladder cancer	0.000271	0.00131	CcSEcCtD
Clobazam—Malnutrition—Methotrexate—urinary bladder cancer	0.00027	0.0013	CcSEcCtD
Clobazam—Headache—Gemcitabine—urinary bladder cancer	0.00027	0.0013	CcSEcCtD
Clobazam—Vomiting—Fluorouracil—urinary bladder cancer	0.000269	0.0013	CcSEcCtD
Clobazam—Rash—Fluorouracil—urinary bladder cancer	0.000267	0.00129	CcSEcCtD
Clobazam—Dermatitis—Fluorouracil—urinary bladder cancer	0.000267	0.00129	CcSEcCtD
Clobazam—Headache—Fluorouracil—urinary bladder cancer	0.000265	0.00128	CcSEcCtD
Clobazam—Asthenia—Etoposide—urinary bladder cancer	0.000264	0.00127	CcSEcCtD
Clobazam—Pruritus—Etoposide—urinary bladder cancer	0.00026	0.00126	CcSEcCtD
Clobazam—Visual impairment—Doxorubicin—urinary bladder cancer	0.000259	0.00125	CcSEcCtD
Clobazam—Nausea—Gemcitabine—urinary bladder cancer	0.000256	0.00123	CcSEcCtD
Clobazam—Vomiting—Cisplatin—urinary bladder cancer	0.000255	0.00123	CcSEcCtD
Clobazam—Vision blurred—Methotrexate—urinary bladder cancer	0.000254	0.00123	CcSEcCtD
Clobazam—Mental disorder—Epirubicin—urinary bladder cancer	0.000254	0.00123	CcSEcCtD
Clobazam—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000254	0.00122	CcSEcCtD
Clobazam—Rash—Cisplatin—urinary bladder cancer	0.000253	0.00122	CcSEcCtD
Clobazam—Dermatitis—Cisplatin—urinary bladder cancer	0.000253	0.00122	CcSEcCtD
Clobazam—Malnutrition—Epirubicin—urinary bladder cancer	0.000252	0.00122	CcSEcCtD
Clobazam—Diarrhoea—Etoposide—urinary bladder cancer	0.000251	0.00121	CcSEcCtD
Clobazam—Nausea—Fluorouracil—urinary bladder cancer	0.000251	0.00121	CcSEcCtD
Clobazam—Eye disorder—Doxorubicin—urinary bladder cancer	0.000251	0.00121	CcSEcCtD
Clobazam—Anaemia—Methotrexate—urinary bladder cancer	0.000249	0.0012	CcSEcCtD
Clobazam—Tension—Epirubicin—urinary bladder cancer	0.000248	0.0012	CcSEcCtD
Clobazam—Nervousness—Epirubicin—urinary bladder cancer	0.000245	0.00118	CcSEcCtD
Clobazam—Dizziness—Etoposide—urinary bladder cancer	0.000243	0.00117	CcSEcCtD
Clobazam—Muscle spasms—Epirubicin—urinary bladder cancer	0.000243	0.00117	CcSEcCtD
Clobazam—Leukopenia—Methotrexate—urinary bladder cancer	0.000241	0.00117	CcSEcCtD
Clobazam—Nausea—Cisplatin—urinary bladder cancer	0.000238	0.00115	CcSEcCtD
Clobazam—Vision blurred—Epirubicin—urinary bladder cancer	0.000238	0.00115	CcSEcCtD
Clobazam—Cough—Methotrexate—urinary bladder cancer	0.000235	0.00114	CcSEcCtD
Clobazam—Mental disorder—Doxorubicin—urinary bladder cancer	0.000235	0.00113	CcSEcCtD
Clobazam—Vomiting—Etoposide—urinary bladder cancer	0.000234	0.00113	CcSEcCtD
Clobazam—Malnutrition—Doxorubicin—urinary bladder cancer	0.000234	0.00113	CcSEcCtD
Clobazam—Anaemia—Epirubicin—urinary bladder cancer	0.000233	0.00113	CcSEcCtD
Clobazam—Agitation—Epirubicin—urinary bladder cancer	0.000232	0.00112	CcSEcCtD
Clobazam—Rash—Etoposide—urinary bladder cancer	0.000232	0.00112	CcSEcCtD
Clobazam—Dermatitis—Etoposide—urinary bladder cancer	0.000231	0.00112	CcSEcCtD
Clobazam—Headache—Etoposide—urinary bladder cancer	0.00023	0.00111	CcSEcCtD
Clobazam—Myalgia—Methotrexate—urinary bladder cancer	0.00023	0.00111	CcSEcCtD
Clobazam—Tension—Doxorubicin—urinary bladder cancer	0.000229	0.00111	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000228	0.0011	CcSEcCtD
Clobazam—Nervousness—Doxorubicin—urinary bladder cancer	0.000227	0.00109	CcSEcCtD
Clobazam—ABCB1—lymph node—urinary bladder cancer	0.000226	0.00609	CbGeAlD
Clobazam—Leukopenia—Epirubicin—urinary bladder cancer	0.000226	0.00109	CcSEcCtD
Clobazam—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000225	0.00108	CcSEcCtD
Clobazam—Confusional state—Methotrexate—urinary bladder cancer	0.000222	0.00107	CcSEcCtD
Clobazam—Cough—Epirubicin—urinary bladder cancer	0.00022	0.00106	CcSEcCtD
Clobazam—Vision blurred—Doxorubicin—urinary bladder cancer	0.00022	0.00106	CcSEcCtD
Clobazam—Infection—Methotrexate—urinary bladder cancer	0.000219	0.00106	CcSEcCtD
Clobazam—Nausea—Etoposide—urinary bladder cancer	0.000218	0.00105	CcSEcCtD
Clobazam—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000216	0.00104	CcSEcCtD
Clobazam—Anaemia—Doxorubicin—urinary bladder cancer	0.000216	0.00104	CcSEcCtD
Clobazam—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000216	0.00104	CcSEcCtD
Clobazam—Myalgia—Epirubicin—urinary bladder cancer	0.000215	0.00104	CcSEcCtD
Clobazam—Agitation—Doxorubicin—urinary bladder cancer	0.000215	0.00104	CcSEcCtD
Clobazam—Anxiety—Epirubicin—urinary bladder cancer	0.000214	0.00103	CcSEcCtD
Clobazam—Skin disorder—Methotrexate—urinary bladder cancer	0.000214	0.00103	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000213	0.00103	CcSEcCtD
Clobazam—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000213	0.00103	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000211	0.00147	CbGpPWpGaD
Clobazam—Dry mouth—Epirubicin—urinary bladder cancer	0.00021	0.00101	CcSEcCtD
Clobazam—Anorexia—Methotrexate—urinary bladder cancer	0.00021	0.00101	CcSEcCtD
Clobazam—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000209	0.00146	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000209	0.00146	CbGpPWpGaD
Clobazam—Leukopenia—Doxorubicin—urinary bladder cancer	0.000209	0.00101	CcSEcCtD
Clobazam—Confusional state—Epirubicin—urinary bladder cancer	0.000208	0.001	CcSEcCtD
Clobazam—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000206	0.00144	CbGpPWpGaD
Clobazam—Hypotension—Methotrexate—urinary bladder cancer	0.000206	0.000993	CcSEcCtD
Clobazam—Infection—Epirubicin—urinary bladder cancer	0.000205	0.000988	CcSEcCtD
Clobazam—GABRG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000204	0.00143	CbGpPWpGaD
Clobazam—Cough—Doxorubicin—urinary bladder cancer	0.000204	0.000984	CcSEcCtD
Clobazam—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000202	0.000975	CcSEcCtD
Clobazam—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000202	0.000974	CcSEcCtD
Clobazam—CYP2B6—Biological oxidations—HPGDS—urinary bladder cancer	0.000202	0.00141	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000201	0.000968	CcSEcCtD
Clobazam—Skin disorder—Epirubicin—urinary bladder cancer	0.0002	0.000966	CcSEcCtD
Clobazam—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000199	0.000961	CcSEcCtD
Clobazam—Insomnia—Methotrexate—urinary bladder cancer	0.000199	0.000961	CcSEcCtD
Clobazam—Myalgia—Doxorubicin—urinary bladder cancer	0.000199	0.00096	CcSEcCtD
Clobazam—Anxiety—Doxorubicin—urinary bladder cancer	0.000198	0.000956	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000197	0.000953	CcSEcCtD
Clobazam—Anorexia—Epirubicin—urinary bladder cancer	0.000196	0.000948	CcSEcCtD
Clobazam—Somnolence—Methotrexate—urinary bladder cancer	0.000196	0.000945	CcSEcCtD
Clobazam—CYP2B6—Biological oxidations—GSTT1—urinary bladder cancer	0.000196	0.00137	CbGpPWpGaD
Clobazam—Dry mouth—Doxorubicin—urinary bladder cancer	0.000194	0.000939	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000193	0.00134	CbGpPWpGaD
Clobazam—Hypotension—Epirubicin—urinary bladder cancer	0.000192	0.000929	CcSEcCtD
Clobazam—Confusional state—Doxorubicin—urinary bladder cancer	0.000192	0.000928	CcSEcCtD
Clobazam—Decreased appetite—Methotrexate—urinary bladder cancer	0.000191	0.000924	CcSEcCtD
Clobazam—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000191	0.00134	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.000191	0.00133	CbGpPWpGaD
Clobazam—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00019	0.000917	CcSEcCtD
Clobazam—Fatigue—Methotrexate—urinary bladder cancer	0.00019	0.000916	CcSEcCtD
Clobazam—Infection—Doxorubicin—urinary bladder cancer	0.000189	0.000914	CcSEcCtD
Clobazam—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000189	0.00132	CbGpPWpGaD
Clobazam—GABRA1—Orphan transporters—CREBBP—urinary bladder cancer	0.000189	0.00132	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000188	0.00131	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000188	0.000906	CcSEcCtD
Clobazam—SLC6A11—Metabolism—NQO1—urinary bladder cancer	0.000187	0.00131	CbGpPWpGaD
Clobazam—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000187	0.000902	CcSEcCtD
Clobazam—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000187	0.000901	CcSEcCtD
Clobazam—Insomnia—Epirubicin—urinary bladder cancer	0.000186	0.000899	CcSEcCtD
Clobazam—Skin disorder—Doxorubicin—urinary bladder cancer	0.000185	0.000894	CcSEcCtD
Clobazam—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000184	0.000889	CcSEcCtD
Clobazam—Somnolence—Epirubicin—urinary bladder cancer	0.000183	0.000884	CcSEcCtD
Clobazam—SLC6A11—Neuronal System—HRAS—urinary bladder cancer	0.000183	0.00128	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000182	0.00127	CbGpPWpGaD
Clobazam—Anorexia—Doxorubicin—urinary bladder cancer	0.000182	0.000877	CcSEcCtD
Clobazam—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000181	0.000876	CcSEcCtD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000179	0.00125	CbGpPWpGaD
Clobazam—Decreased appetite—Epirubicin—urinary bladder cancer	0.000179	0.000864	CcSEcCtD
Clobazam—GABRA1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000179	0.00125	CbGpPWpGaD
Clobazam—Hypotension—Doxorubicin—urinary bladder cancer	0.000178	0.00086	CcSEcCtD
Clobazam—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000178	0.000858	CcSEcCtD
Clobazam—Fatigue—Epirubicin—urinary bladder cancer	0.000178	0.000857	CcSEcCtD
Clobazam—Constipation—Epirubicin—urinary bladder cancer	0.000176	0.00085	CcSEcCtD
Clobazam—Urticaria—Methotrexate—urinary bladder cancer	0.000175	0.000844	CcSEcCtD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000174	0.00122	CbGpPWpGaD
Clobazam—Body temperature increased—Methotrexate—urinary bladder cancer	0.000174	0.00084	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000174	0.000838	CcSEcCtD
Clobazam—Insomnia—Doxorubicin—urinary bladder cancer	0.000172	0.000832	CcSEcCtD
Clobazam—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000172	0.0012	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.00017	0.00119	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00017	0.00119	CbGpPWpGaD
Clobazam—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00017	0.000819	CcSEcCtD
Clobazam—Somnolence—Doxorubicin—urinary bladder cancer	0.000169	0.000818	CcSEcCtD
Clobazam—CYP2C18—Metabolism—GSTZ1—urinary bladder cancer	0.000169	0.00118	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000167	0.00116	CbGpPWpGaD
Clobazam—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000166	0.0008	CcSEcCtD
Clobazam—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000794	CcSEcCtD
Clobazam—Fatigue—Doxorubicin—urinary bladder cancer	0.000164	0.000793	CcSEcCtD
Clobazam—Urticaria—Epirubicin—urinary bladder cancer	0.000164	0.00079	CcSEcCtD
Clobazam—Constipation—Doxorubicin—urinary bladder cancer	0.000163	0.000787	CcSEcCtD
Clobazam—Body temperature increased—Epirubicin—urinary bladder cancer	0.000163	0.000786	CcSEcCtD
Clobazam—CYP2C18—Metabolism—NAT1—urinary bladder cancer	0.00016	0.00112	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GSTO2—urinary bladder cancer	0.00016	0.00112	CbGpPWpGaD
Clobazam—Asthenia—Methotrexate—urinary bladder cancer	0.000158	0.000762	CcSEcCtD
Clobazam—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000157	0.000758	CcSEcCtD
Clobazam—SLC6A11—Metabolism—GSTP1—urinary bladder cancer	0.000156	0.00109	CbGpPWpGaD
Clobazam—Pruritus—Methotrexate—urinary bladder cancer	0.000156	0.000752	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000153	0.00107	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000152	0.00106	CbGpPWpGaD
Clobazam—Urticaria—Doxorubicin—urinary bladder cancer	0.000151	0.000731	CcSEcCtD
Clobazam—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000151	0.000727	CcSEcCtD
Clobazam—Diarrhoea—Methotrexate—urinary bladder cancer	0.000151	0.000727	CcSEcCtD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000148	0.00104	CbGpPWpGaD
Clobazam—Asthenia—Epirubicin—urinary bladder cancer	0.000148	0.000713	CcSEcCtD
Clobazam—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000148	0.00103	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—HRAS—urinary bladder cancer	0.000148	0.00103	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—UGT2B7—urinary bladder cancer	0.000146	0.00102	CbGpPWpGaD
Clobazam—Pruritus—Epirubicin—urinary bladder cancer	0.000146	0.000704	CcSEcCtD
Clobazam—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000146	0.00102	CbGpPWpGaD
Clobazam—Dizziness—Methotrexate—urinary bladder cancer	0.000146	0.000703	CcSEcCtD
Clobazam—SLC6A11—Metabolism—TYMS—urinary bladder cancer	0.000145	0.00101	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—NCOR1—urinary bladder cancer	0.000144	0.001	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—GSTM1—urinary bladder cancer	0.000144	0.001	CbGpPWpGaD
Clobazam—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000143	0.000995	CbGpPWpGaD
Clobazam—Diarrhoea—Epirubicin—urinary bladder cancer	0.000141	0.00068	CcSEcCtD
Clobazam—Vomiting—Methotrexate—urinary bladder cancer	0.00014	0.000676	CcSEcCtD
Clobazam—Rash—Methotrexate—urinary bladder cancer	0.000139	0.00067	CcSEcCtD
Clobazam—Dermatitis—Methotrexate—urinary bladder cancer	0.000139	0.000669	CcSEcCtD
Clobazam—Headache—Methotrexate—urinary bladder cancer	0.000138	0.000666	CcSEcCtD
Clobazam—SLC6A11—Metabolism—GPX1—urinary bladder cancer	0.000138	0.00096	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000137	0.000955	CbGpPWpGaD
Clobazam—Asthenia—Doxorubicin—urinary bladder cancer	0.000137	0.00066	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000136	0.000952	CbGpPWpGaD
Clobazam—Dizziness—Epirubicin—urinary bladder cancer	0.000136	0.000658	CcSEcCtD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000136	0.00095	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000136	0.000949	CbGpPWpGaD
Clobazam—CYP2B6—Biological oxidations—GSTP1—urinary bladder cancer	0.000136	0.000946	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—ERCC2—urinary bladder cancer	0.000135	0.000943	CbGpPWpGaD
Clobazam—Pruritus—Doxorubicin—urinary bladder cancer	0.000135	0.000651	CcSEcCtD
Clobazam—CYP2B6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000134	0.000933	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CYP4B1—urinary bladder cancer	0.000132	0.00092	CbGpPWpGaD
Clobazam—Vomiting—Epirubicin—urinary bladder cancer	0.000131	0.000632	CcSEcCtD
Clobazam—Nausea—Methotrexate—urinary bladder cancer	0.000131	0.000631	CcSEcCtD
Clobazam—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00013	0.00063	CcSEcCtD
Clobazam—Rash—Epirubicin—urinary bladder cancer	0.00013	0.000627	CcSEcCtD
Clobazam—Dermatitis—Epirubicin—urinary bladder cancer	0.00013	0.000626	CcSEcCtD
Clobazam—Headache—Epirubicin—urinary bladder cancer	0.000129	0.000623	CcSEcCtD
Clobazam—SLC6A11—Metabolism—MTHFR—urinary bladder cancer	0.000127	0.000886	CbGpPWpGaD
Clobazam—Dizziness—Doxorubicin—urinary bladder cancer	0.000126	0.000608	CcSEcCtD
Clobazam—CYP2B6—Biological oxidations—GSTM1—urinary bladder cancer	0.000125	0.00087	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—SLC19A1—urinary bladder cancer	0.000125	0.000869	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000124	0.000865	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000123	0.000859	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000123	0.000858	CbGpPWpGaD
Clobazam—Nausea—Epirubicin—urinary bladder cancer	0.000122	0.000591	CcSEcCtD
Clobazam—CYP2C18—Metabolism—PRSS3—urinary bladder cancer	0.000121	0.000847	CbGpPWpGaD
Clobazam—Vomiting—Doxorubicin—urinary bladder cancer	0.000121	0.000585	CcSEcCtD
Clobazam—Rash—Doxorubicin—urinary bladder cancer	0.00012	0.00058	CcSEcCtD
Clobazam—Dermatitis—Doxorubicin—urinary bladder cancer	0.00012	0.00058	CcSEcCtD
Clobazam—Headache—Doxorubicin—urinary bladder cancer	0.000119	0.000576	CcSEcCtD
Clobazam—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000115	0.0008	CbGpPWpGaD
Clobazam—Nausea—Doxorubicin—urinary bladder cancer	0.000113	0.000547	CcSEcCtD
Clobazam—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000113	0.000789	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000113	0.000786	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00011	0.000768	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000109	0.000764	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000108	0.000756	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PPARG—urinary bladder cancer	0.000103	0.000718	CbGpPWpGaD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000103	0.000716	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000102	0.000715	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000101	0.000705	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CREBBP—urinary bladder cancer	9.89e-05	0.00069	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.84e-05	0.000687	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—TYMP—urinary bladder cancer	9.7e-05	0.000677	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	9.41e-05	0.000657	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	9.36e-05	0.000653	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	9.29e-05	0.000648	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.28e-05	0.000648	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	9.27e-05	0.000647	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.16e-05	0.00064	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8.96e-05	0.000626	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	8.95e-05	0.000624	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	8.89e-05	0.00062	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—NAT2—urinary bladder cancer	8.77e-05	0.000612	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	8.7e-05	0.000608	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.67e-05	0.000605	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	8.55e-05	0.000597	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	8.3e-05	0.00058	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTGS2—urinary bladder cancer	8.1e-05	0.000565	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.93e-05	0.000553	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NAT1—urinary bladder cancer	7.87e-05	0.00055	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	7.87e-05	0.00055	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	7.57e-05	0.000529	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—RRM2—urinary bladder cancer	7.57e-05	0.000529	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	7.54e-05	0.000526	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.31e-05	0.00051	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	7.2e-05	0.000503	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTEN—urinary bladder cancer	7.06e-05	0.000493	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—ENO2—urinary bladder cancer	7.01e-05	0.00049	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—HPGDS—urinary bladder cancer	7.01e-05	0.00049	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.93e-05	0.000484	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GSTT1—urinary bladder cancer	6.8e-05	0.000475	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—EP300—urinary bladder cancer	6.73e-05	0.00047	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.69e-05	0.000467	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.66e-05	0.000465	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.64e-05	0.000463	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.52e-05	0.000455	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	6.52e-05	0.000455	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	6.48e-05	0.000453	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	6.28e-05	0.000438	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.16e-05	0.00043	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	6.13e-05	0.000428	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	6.12e-05	0.000427	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.08e-05	0.000424	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	5.97e-05	0.000416	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.96e-05	0.000416	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	5.95e-05	0.000415	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NAT1—urinary bladder cancer	5.95e-05	0.000415	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.85e-05	0.000408	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.82e-05	0.000406	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GSTO2—urinary bladder cancer	5.81e-05	0.000405	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NAT1—urinary bladder cancer	5.81e-05	0.000405	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.76e-05	0.000402	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.74e-05	0.000401	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.66e-05	0.000395	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—NQO1—urinary bladder cancer	5.65e-05	0.000395	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.58e-05	0.00039	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	5.44e-05	0.00038	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	5.31e-05	0.000371	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.27e-05	0.000368	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.21e-05	0.000364	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—HRAS—urinary bladder cancer	4.99e-05	0.000349	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.94e-05	0.000344	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.9e-05	0.000342	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.87e-05	0.00034	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.78e-05	0.000334	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—TYMP—urinary bladder cancer	4.77e-05	0.000333	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.76e-05	0.000332	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GSTP1—urinary bladder cancer	4.72e-05	0.000329	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	4.63e-05	0.000323	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.6e-05	0.000321	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—HRAS—urinary bladder cancer	4.57e-05	0.000319	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	4.52e-05	0.000315	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.51e-05	0.000315	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PRSS3—urinary bladder cancer	4.4e-05	0.000307	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—TYMS—urinary bladder cancer	4.38e-05	0.000306	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GSTM1—urinary bladder cancer	4.33e-05	0.000302	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—NCOR1—urinary bladder cancer	4.33e-05	0.000302	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NAT2—urinary bladder cancer	4.31e-05	0.000301	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.3e-05	0.0003	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.16e-05	0.000291	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.15e-05	0.00029	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GPX1—urinary bladder cancer	4.15e-05	0.00029	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—ERCC2—urinary bladder cancer	4.07e-05	0.000284	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—HRAS—urinary bladder cancer	3.99e-05	0.000279	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.96e-05	0.000277	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.85e-05	0.000269	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—MTHFR—urinary bladder cancer	3.83e-05	0.000267	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.77e-05	0.000263	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.72e-05	0.00026	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.61e-05	0.000252	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.6e-05	0.000252	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.58e-05	0.00025	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.58e-05	0.00025	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.52e-05	0.000246	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.46e-05	0.000242	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.45e-05	0.000241	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—ENO2—urinary bladder cancer	3.45e-05	0.000241	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	3.45e-05	0.000241	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.38e-05	0.000236	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	3.34e-05	0.000233	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.27e-05	0.000228	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.26e-05	0.000228	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.22e-05	0.000224	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.19e-05	0.000223	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.18e-05	0.000222	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PPARG—urinary bladder cancer	3.11e-05	0.000217	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CREBBP—urinary bladder cancer	2.98e-05	0.000208	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.95e-05	0.000206	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.84e-05	0.000198	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.81e-05	0.000196	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.78e-05	0.000194	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.78e-05	0.000194	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.75e-05	0.000192	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.71e-05	0.000189	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.61e-05	0.000182	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.61e-05	0.000182	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.59e-05	0.000181	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.54e-05	0.000178	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.54e-05	0.000178	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.53e-05	0.000176	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.49e-05	0.000174	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.47e-05	0.000172	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTGS2—urinary bladder cancer	2.44e-05	0.000171	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	2.32e-05	0.000162	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.31e-05	0.000161	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.17e-05	0.000151	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—TYMS—urinary bladder cancer	2.16e-05	0.00015	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.13e-05	0.000149	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTEN—urinary bladder cancer	2.13e-05	0.000149	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.13e-05	0.000149	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.1e-05	0.000147	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.05e-05	0.000143	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GPX1—urinary bladder cancer	2.04e-05	0.000142	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.04e-05	0.000142	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—EP300—urinary bladder cancer	2.03e-05	0.000142	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	2e-05	0.00014	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.96e-05	0.000137	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.88e-05	0.000131	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.78e-05	0.000124	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.75e-05	0.000122	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.71e-05	0.000119	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.69e-05	0.000118	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.69e-05	0.000118	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.63e-05	0.000114	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.61e-05	0.000112	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.61e-05	0.000112	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.59e-05	0.000111	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.57e-05	0.00011	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.57e-05	0.00011	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.57e-05	0.000109	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.57e-05	0.000109	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.54e-05	0.000108	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.53e-05	0.000107	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.52e-05	0.000106	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.51e-05	0.000106	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.5e-05	0.000105	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.48e-05	0.000103	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.47e-05	0.000102	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.42e-05	9.93e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.39e-05	9.69e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.26e-05	8.82e-05	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.2e-05	8.38e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.15e-05	8.05e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.13e-05	7.86e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.11e-05	7.74e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.08e-05	7.55e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.05e-05	7.35e-05	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.05e-05	7.31e-05	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—EP300—urinary bladder cancer	9.99e-06	6.97e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.79e-06	6.84e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.68e-06	6.76e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.68e-06	6.76e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.27e-06	6.47e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.1e-06	6.35e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	9.08e-06	6.34e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTGS2—urinary bladder cancer	8.86e-06	6.18e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.56e-06	5.97e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTEN—urinary bladder cancer	7.91e-06	5.52e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTEN—urinary bladder cancer	7.73e-06	5.39e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—EP300—urinary bladder cancer	7.55e-06	5.27e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—EP300—urinary bladder cancer	7.37e-06	5.14e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.94e-06	4.84e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.66e-06	4.65e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.46e-06	3.81e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.76e-06	3.32e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.54e-06	3.17e-05	CbGpPWpGaD
